-+ 0.00%
-+ 0.00%
-+ 0.00%
Apnimed Q3 EPS $(1.05) Misses $(0.59) Estimate, Sales $2.480M Down From $8.802M YoY
Share
Listen to the news
Apnimed (NASDAQ:APMD) reported quarterly losses of $(1.05) per share which missed the analyst consensus estimate of $(0.59) by 77.97 percent. This is a 42.62 percent increase over losses of $(1.83) per share from the same period last year. The company reported $2.480 million in sales this quarter. This is a 71.82 percent decrease over sales of $8.802 million the same period last year.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending